Phosphatidylserine
RCTs in older adults with memory complaints or mild cognitive impairment report memory benefits, though often only in subgroups: soy PS at 100–300mg/day for 6 months helped only participants with low baseline scores (Kato-Kataoka 2010), and marine PS-DHA at 300mg/day improved immediate verbal recall in an exploratory 15-week trial (Vakhapova 2010). A 2026 network meta-analysis in MCI/Alzheimer's found PS 100mg improved MMSE but not the stricter ADAS-Cog scale. In healthy children, a 12-week RCT of 100mg sunflower PS found no effect on primary or secondary outcomes (Friling 2025; authors include staff of IFF, the product's manufacturer). A positive 2024 MCI trial (Duan 2024; BYHEALTH co-authors) gave only 31.5mg PS inside a multi-ingredient formula. The FDA's qualified health claim for dementia risk must be labelled as based on 'very limited and preliminary' research.
エビデンス確認日:
作用機序
Phosphatidylserine (PS) is a phospholipid that forms a critical component of neuronal cell membranes. It supports signal transduction across synapses, facilitates acetylcholine and dopamine release, and modulates cortisol secretion. Supplementation replenishes PS levels that decline naturally with age.
臨床エビデンスの概要
RCTs in older adults with memory complaints or mild cognitive impairment report memory benefits, though often only in subgroups: soy PS at 100–300mg/day for 6 months helped only participants with low baseline scores (Kato-Kataoka 2010), and marine PS-DHA at 300mg/day improved immediate verbal recall in an exploratory 15-week trial (Vakhapova 2010). A 2026 network meta-analysis in MCI/Alzheimer's found PS 100mg improved MMSE but not the stricter ADAS-Cog scale. In healthy children, a 12-week RCT of 100mg sunflower PS found no effect on primary or secondary outcomes (Friling 2025; authors include staff of IFF, the product's manufacturer). A positive 2024 MCI trial (Duan 2024; BYHEALTH co-authors) gave only 31.5mg PS inside a multi-ingredient formula. The FDA's qualified health claim for dementia risk must be labelled as based on 'very limited and preliminary' research.
ヒト効果マトリクス
Based on human clinical trials only. Animal and in-vitro data excluded.
| 効果 | エビデンス | 効果の大きさ | 研究数 |
|---|---|---|---|
| Memory Recall | strong | 中 | 4 |
| Cortisol Reduction | moderate | 中 | — |
| Processing Speed | moderate | 小 | — |
| Age-Related Cognitive Decline | moderate | 小 | 1 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
実証された効果
- Memory recall in older adults with memory complaints (often subgroup-only)
- MMSE scores in MCI/Alzheimer's (network meta-analysis)
- Cortisol reduction under stress (not re-verified in our 2026 review)
副作用と注意事項
- Well tolerated — no safety differences versus placebo over 15 weeks at 300mg/day
- Mild GI discomfort in some users
- Open-label 100mg/day extension: small drop in resting diastolic blood pressure and slight weight gain
摂取方法
スタッキングの推奨
Phosphatidylserineと相性の良い成分とその理由。
PS maintains cell membrane integrity while Lion's Mane drives NGF synthesis. Both support long-term brain health via complementary structural and growth-factor pathways.
Both are membrane phospholipid precursors, but they work on different pathways. Citicoline primarily builds phosphatidylcholine; PS addresses phosphatidylserine. Together they provide comprehensive neuronal membrane support.
DHA is a structural component of neuronal membranes. Some clinical PS products are DHA-conjugated (PS-DHA): a 15-week trial of marine PS-DHA at 300mg/day improved immediate verbal recall in older adults with memory complaints.
よくある質問
Soy-derived vs sunflower PS — which is better?
Both are used in trials: soy PS in older adults with memory complaints (Kato-Kataoka 2010) and sunflower PS in healthy children, where it had no effect (Friling 2025). Sunflower-derived PS is soy-free and is the preferred option for anyone with soy sensitivity. No head-to-head comparison of the two was part of our 2026 review.
What is the FDA health claim for PS?
The FDA allows a qualified health claim that phosphatidylserine may reduce the risk of dementia and cognitive dysfunction in the elderly. It is qualified — not a full health claim — because the FDA judged the evidence insufficient: labels must state that 'very limited and preliminary scientific research suggests' the benefit.
What about the bovine brain source I see mentioned in older studies?
Original 1990s PS trials used bovine-cortex-derived PS. This source was discontinued globally after BSE (mad cow disease) concerns. All current commercial PS is plant- or marine-derived. The later plant- and marine-PS trials show memory benefits mainly in subgroups of older adults, so the older bovine results should not be assumed to transfer.
Does PS interact with blood thinners?
No clinical interaction between PS and anticoagulants was found in our 2026 PubMed review, and the main PS safety trial did not collect bleeding data. If you are on warfarin, aspirin, or other anticoagulants, consult your doctor before adding any supplement.
Top stacks containing Phosphatidylserine
Phosphatidylserine in Japan
Products in Japan
- Mind Lab Pro9.4/10No FFC notification found (checked 2026-10-06)Local price: ¥10,350/month
- Hunter Focus7.7/10No FFC notification found (checked 2026-10-06)Local price: ¥13,500/month
- FANCL BRAINs7.2/10FFC 届出 G425Local price: ¥5,479/month
Consumer Affairs Agency (FFC)
Regulatory note
本ページは教育目的の編集コンテンツであり、医学的助言を構成するものではありません。日本国内で販売される機能性表示食品(FFC)および特定保健用食品(FOSHU)は、消費者庁への届出または許可を必要とします。届出のない輸入品については、日本の薬機法(旧薬事法)の下で疾病治療を示唆する表現は規制されます。サプリメントを開始する前に、必ず資格のある医療専門家にご相談ください。This page is editorial and not medical advice. Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) sold in Japan require notification or approval from the Consumer Affairs Agency. Imported products without notification cannot make disease-treatment claims under the Pharmaceuticals and Medical Devices (PMD) Act. Note: In July 2026, the Consumer Affairs Agency (CAA) opened a public comment period (Notice No. 235080088, closes 30 July 2026) on proposed revisions to permitted claim wording for FFC-notified ingredients including DHA, phosphatidylserine, and NMN; compliant claim language may require updating once the final Cabinet Office Order is published. Consult a qualified healthcare professional before starting any supplement.
出典 (6)展開
- PMID 21103034Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. (2010)
- PMID 20523044Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. (2010)
- PMID 21711517Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension. (2011)
- PMID 39317299Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial. (2024)
- PMID 41318468The cognitive effects of supplementation with sunflower phosphatidyl serine in healthy children aged 8 to 12 years: a randomized controlled trial. (2025)
- PMID 42494057The impact of supplements on cognitive function for Alzheimer's disease or mild cognitive impairment: a systematic review and network meta-analysis. (2026)